Joshua Lawrence Roffman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 34 | 2023 | 6987 | 2.280 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 10 | 2014 | 276 | 2.040 |
Why?
|
| Folic Acid | 10 | 2022 | 1336 | 1.940 |
Why?
|
| Memory, Short-Term | 4 | 2020 | 1010 | 1.140 |
Why?
|
| Schizophrenic Psychology | 7 | 2016 | 1651 | 1.020 |
Why?
|
| Cerebral Cortex | 12 | 2024 | 5834 | 0.900 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2021 | 2541 | 0.890 |
Why?
|
| Psychiatry | 4 | 2019 | 1716 | 0.830 |
Why?
|
| Catechol O-Methyltransferase | 5 | 2014 | 251 | 0.790 |
Why?
|
| Vitamin B Complex | 3 | 2019 | 299 | 0.760 |
Why?
|
| Cognition | 10 | 2023 | 7080 | 0.720 |
Why?
|
| Food, Fortified | 2 | 2018 | 189 | 0.690 |
Why?
|
| Grasshoppers | 1 | 2019 | 20 | 0.690 |
Why?
|
| Psychotic Disorders | 9 | 2024 | 3279 | 0.680 |
Why?
|
| Tetrahydrofolates | 2 | 2017 | 58 | 0.660 |
Why?
|
| Neural Tube Defects | 2 | 2018 | 255 | 0.650 |
Why?
|
| Brain | 24 | 2024 | 27476 | 0.650 |
Why?
|
| Vitamin B 12 | 3 | 2019 | 528 | 0.570 |
Why?
|
| Antipsychotic Agents | 4 | 2023 | 3081 | 0.540 |
Why?
|
| Vitamins | 2 | 2016 | 1638 | 0.540 |
Why?
|
| Habits | 1 | 2017 | 148 | 0.540 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2016 | 26 | 0.530 |
Why?
|
| Child Development | 3 | 2024 | 2337 | 0.520 |
Why?
|
| Polymorphism, Genetic | 5 | 2011 | 4251 | 0.500 |
Why?
|
| Human Development | 3 | 2021 | 123 | 0.500 |
Why?
|
| Prefrontal Cortex | 8 | 2020 | 2257 | 0.500 |
Why?
|
| Dietary Supplements | 3 | 2018 | 3442 | 0.490 |
Why?
|
| DNA Methylation | 6 | 2018 | 4432 | 0.490 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2016 | 293 | 0.470 |
Why?
|
| Nerve Net | 7 | 2023 | 2361 | 0.440 |
Why?
|
| Psychotherapy, Brief | 1 | 2014 | 118 | 0.440 |
Why?
|
| Mental Disorders | 4 | 2021 | 6879 | 0.430 |
Why?
|
| Hippocampus | 7 | 2021 | 3786 | 0.430 |
Why?
|
| Dopamine | 3 | 2016 | 1617 | 0.410 |
Why?
|
| Neural Pathways | 3 | 2020 | 3120 | 0.400 |
Why?
|
| Goals | 1 | 2017 | 716 | 0.390 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 958 | 0.380 |
Why?
|
| Genome-Wide Association Study | 17 | 2022 | 12798 | 0.380 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 1470 | 0.360 |
Why?
|
| Brain Mapping | 13 | 2020 | 6740 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2024 | 36861 | 0.320 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2022 | 16051 | 0.320 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3743 | 0.310 |
Why?
|
| Impulsive Behavior | 2 | 2024 | 349 | 0.300 |
Why?
|
| Population Surveillance | 1 | 2018 | 2597 | 0.300 |
Why?
|
| Cognition Disorders | 5 | 2017 | 3985 | 0.290 |
Why?
|
| Corpus Striatum | 4 | 2021 | 1237 | 0.290 |
Why?
|
| Motivation | 1 | 2017 | 2030 | 0.280 |
Why?
|
| Mental Health Services | 1 | 2019 | 1732 | 0.280 |
Why?
|
| Gyrus Cinguli | 3 | 2016 | 1136 | 0.270 |
Why?
|
| Adult | 50 | 2024 | 223818 | 0.270 |
Why?
|
| Humans | 87 | 2024 | 768887 | 0.270 |
Why?
|
| Neurogenesis | 1 | 2013 | 865 | 0.270 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1813 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2022 | 18065 | 0.250 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 188 | 0.250 |
Why?
|
| S-Adenosylmethionine | 2 | 2018 | 219 | 0.240 |
Why?
|
| Depressive Disorder, Major | 4 | 2019 | 4819 | 0.240 |
Why?
|
| Genotype | 14 | 2017 | 13048 | 0.230 |
Why?
|
| Amygdala | 3 | 2021 | 1382 | 0.230 |
Why?
|
| Female | 53 | 2024 | 397464 | 0.220 |
Why?
|
| Adolescent | 23 | 2023 | 89247 | 0.210 |
Why?
|
| Male | 51 | 2024 | 365249 | 0.200 |
Why?
|
| Bipolar Disorder | 5 | 2020 | 5131 | 0.200 |
Why?
|
| Mothers | 2 | 2024 | 2211 | 0.200 |
Why?
|
| Genetic Variation | 4 | 2020 | 6610 | 0.200 |
Why?
|
| Glutamate Carboxypeptidase II | 2 | 2013 | 90 | 0.190 |
Why?
|
| Dental Enamel | 1 | 2021 | 61 | 0.190 |
Why?
|
| Neurosciences | 1 | 2006 | 385 | 0.190 |
Why?
|
| Sex Characteristics | 3 | 2020 | 2660 | 0.180 |
Why?
|
| Endophenotypes | 2 | 2019 | 258 | 0.180 |
Why?
|
| Signal Transduction | 3 | 2018 | 23652 | 0.170 |
Why?
|
| Young Adult | 20 | 2024 | 60110 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2017 | 6031 | 0.170 |
Why?
|
| Self Efficacy | 1 | 2024 | 643 | 0.170 |
Why?
|
| Psychotherapy | 2 | 2006 | 1654 | 0.170 |
Why?
|
| Efferent Pathways | 1 | 2000 | 165 | 0.170 |
Why?
|
| Epigenesis, Genetic | 5 | 2019 | 3836 | 0.160 |
Why?
|
| Diet | 1 | 2017 | 8090 | 0.160 |
Why?
|
| Positron-Emission Tomography | 5 | 2020 | 6673 | 0.160 |
Why?
|
| Double-Blind Method | 4 | 2019 | 12469 | 0.160 |
Why?
|
| Neurotoxins | 1 | 2000 | 241 | 0.160 |
Why?
|
| Genetic Loci | 6 | 2020 | 2630 | 0.160 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 936 | 0.160 |
Why?
|
| Teaching | 1 | 2006 | 1171 | 0.150 |
Why?
|
| Parenting | 1 | 2024 | 709 | 0.150 |
Why?
|
| Tic Disorders | 1 | 2019 | 140 | 0.150 |
Why?
|
| Philadelphia | 1 | 2018 | 271 | 0.150 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 1895 | 0.150 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 718 | 0.150 |
Why?
|
| Stereotyped Behavior | 1 | 1997 | 135 | 0.140 |
Why?
|
| Dextroamphetamine | 1 | 1997 | 134 | 0.140 |
Why?
|
| Stress, Psychological | 2 | 2024 | 4542 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 117 | 0.140 |
Why?
|
| Cannabis | 1 | 2022 | 446 | 0.130 |
Why?
|
| Linear Models | 3 | 2017 | 5890 | 0.130 |
Why?
|
| Pregnancy | 6 | 2024 | 30175 | 0.130 |
Why?
|
| Alleles | 5 | 2022 | 6901 | 0.130 |
Why?
|
| Drug Therapy, Combination | 3 | 2016 | 6320 | 0.130 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 279 | 0.130 |
Why?
|
| Tourette Syndrome | 1 | 2019 | 400 | 0.130 |
Why?
|
| Cerebellum | 1 | 2023 | 1522 | 0.130 |
Why?
|
| Emotions | 3 | 2024 | 2768 | 0.130 |
Why?
|
| Organ Size | 5 | 2020 | 2268 | 0.130 |
Why?
|
| Child | 11 | 2024 | 80969 | 0.120 |
Why?
|
| Middle Aged | 25 | 2024 | 223740 | 0.120 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 110 | 0.120 |
Why?
|
| Twins | 1 | 2016 | 340 | 0.120 |
Why?
|
| Reaction Time | 2 | 2020 | 2102 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2008 | 3269 | 0.120 |
Why?
|
| Individuality | 2 | 2016 | 307 | 0.120 |
Why?
|
| Verbal Learning | 2 | 2007 | 465 | 0.120 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 276 | 0.120 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2014 | 40 | 0.120 |
Why?
|
| Avitaminosis | 1 | 2014 | 35 | 0.120 |
Why?
|
| Thalamus | 1 | 2021 | 1050 | 0.120 |
Why?
|
| Self Report | 2 | 2024 | 3773 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2005 | 2748 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 1169 | 0.110 |
Why?
|
| Editorial Policies | 1 | 2019 | 460 | 0.110 |
Why?
|
| Communication | 1 | 2008 | 3908 | 0.110 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 1423 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3163 | 0.110 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 1409 | 0.110 |
Why?
|
| Aldehydes | 1 | 2014 | 170 | 0.110 |
Why?
|
| Methylphenidate | 1 | 1997 | 491 | 0.110 |
Why?
|
| Saccades | 2 | 2014 | 235 | 0.110 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 296 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2019 | 1025 | 0.110 |
Why?
|
| CpG Islands | 2 | 2015 | 1210 | 0.110 |
Why?
|
| Genetic Markers | 2 | 2016 | 2604 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2005 | 3726 | 0.100 |
Why?
|
| Inheritance Patterns | 1 | 2015 | 344 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2011 | 3625 | 0.100 |
Why?
|
| Mood Disorders | 1 | 2019 | 1129 | 0.100 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 1462 | 0.100 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2011 | 9 | 0.100 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2011 | 12 | 0.100 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 28 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3233 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 2 | 2016 | 1182 | 0.100 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 419 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3538 | 0.100 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 138 | 0.100 |
Why?
|
| Genomics | 3 | 2022 | 5928 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2020 | 9081 | 0.090 |
Why?
|
| Feedback, Psychological | 1 | 2011 | 97 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2012 | 432 | 0.090 |
Why?
|
| Prenatal Care | 1 | 2018 | 1159 | 0.090 |
Why?
|
| Panic Disorder | 1 | 2014 | 613 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1726 | 0.090 |
Why?
|
| Parietal Lobe | 2 | 2018 | 866 | 0.080 |
Why?
|
| Magnetoencephalography | 2 | 2014 | 642 | 0.080 |
Why?
|
| Mental Health | 1 | 2024 | 3275 | 0.080 |
Why?
|
| Substantia Nigra | 1 | 2011 | 348 | 0.080 |
Why?
|
| Executive Function | 1 | 2018 | 1405 | 0.080 |
Why?
|
| Motor Activity | 3 | 2013 | 2722 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2017 | 1627 | 0.080 |
Why?
|
| Aspartic Acid | 2 | 2002 | 577 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 1094 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2017 | 65485 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2014 | 1058 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2055 | 0.070 |
Why?
|
| Pteroylpolyglutamic Acids | 1 | 2007 | 9 | 0.070 |
Why?
|
| Anisotropy | 1 | 2011 | 1295 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 26384 | 0.070 |
Why?
|
| Phenotype | 4 | 2016 | 16735 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4879 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 800 | 0.070 |
Why?
|
| Valine | 1 | 2008 | 410 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 2 | 2008 | 2736 | 0.070 |
Why?
|
| Speech Acoustics | 1 | 2007 | 155 | 0.070 |
Why?
|
| Depression | 3 | 2021 | 8240 | 0.070 |
Why?
|
| Neurons | 3 | 2022 | 9524 | 0.070 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 7148 | 0.070 |
Why?
|
| Social Behavior | 1 | 2012 | 1146 | 0.060 |
Why?
|
| Methionine | 1 | 2008 | 573 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2006 | 5956 | 0.060 |
Why?
|
| Association Learning | 1 | 2007 | 223 | 0.060 |
Why?
|
| Verbal Behavior | 1 | 2007 | 336 | 0.060 |
Why?
|
| Risk Factors | 7 | 2022 | 74971 | 0.060 |
Why?
|
| Case-Control Studies | 6 | 2022 | 22294 | 0.060 |
Why?
|
| Malnutrition | 1 | 2012 | 631 | 0.060 |
Why?
|
| Massachusetts | 1 | 2018 | 8888 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15955 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1989 | 0.060 |
Why?
|
| Oximes | 1 | 2005 | 303 | 0.060 |
Why?
|
| Professional Practice | 1 | 2006 | 314 | 0.060 |
Why?
|
| Homocysteine | 1 | 2007 | 637 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1741 | 0.060 |
Why?
|
| Auditory Cortex | 1 | 2008 | 365 | 0.060 |
Why?
|
| Age of Onset | 1 | 2011 | 3346 | 0.050 |
Why?
|
| Rest | 2 | 2019 | 951 | 0.050 |
Why?
|
| Learning | 1 | 2013 | 1761 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 3 | 2014 | 1364 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2006 | 3782 | 0.050 |
Why?
|
| Auditory Perception | 1 | 2008 | 588 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 4415 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2016 | 540 | 0.050 |
Why?
|
| Anorexia Nervosa | 1 | 2012 | 1364 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2011 | 3411 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3858 | 0.050 |
Why?
|
| Speech Perception | 1 | 2007 | 512 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2592 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1177 | 0.050 |
Why?
|
| Aging | 3 | 2015 | 8765 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2009 | 1728 | 0.050 |
Why?
|
| Genome, Human | 1 | 2015 | 4456 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2008 | 1531 | 0.050 |
Why?
|
| Animals | 7 | 2019 | 169408 | 0.050 |
Why?
|
| Tooth, Deciduous | 1 | 2021 | 76 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 1883 | 0.050 |
Why?
|
| Mental Recall | 1 | 2007 | 1226 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 2914 | 0.040 |
Why?
|
| Canada | 1 | 2006 | 2129 | 0.040 |
Why?
|
| Vitamin D | 1 | 2014 | 3311 | 0.040 |
Why?
|
| Legislation, Drug | 1 | 2022 | 216 | 0.040 |
Why?
|
| Time Factors | 3 | 2018 | 40266 | 0.040 |
Why?
|
| Aged | 10 | 2021 | 171790 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1141 | 0.040 |
Why?
|
| England | 1 | 2021 | 533 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2002 | 8200 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 4429 | 0.040 |
Why?
|
| Histone Deacetylase 2 | 1 | 2019 | 72 | 0.040 |
Why?
|
| Glutamate Decarboxylase | 1 | 2000 | 239 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 2000 | 190 | 0.040 |
Why?
|
| Affect | 1 | 2007 | 1500 | 0.040 |
Why?
|
| Denervation | 1 | 2000 | 265 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 2831 | 0.040 |
Why?
|
| Amphetamine | 1 | 2000 | 225 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10397 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2019 | 133 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4123 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2007 | 6242 | 0.040 |
Why?
|
| Adamantane | 1 | 2019 | 148 | 0.040 |
Why?
|
| Child Behavior | 1 | 2024 | 865 | 0.040 |
Why?
|
| Carbon Radioisotopes | 1 | 2019 | 567 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 1438 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15471 | 0.040 |
Why?
|
| Anxiety | 2 | 2024 | 4677 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2006 | 2507 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2019 | 41800 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 93 | 0.030 |
Why?
|
| Attention | 1 | 2007 | 2425 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 77 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 130 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2019 | 483 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 59738 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1904 | 0.030 |
Why?
|
| Perception | 1 | 2022 | 1209 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 14795 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 2734 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 494 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2022 | 810 | 0.030 |
Why?
|
| Risk | 1 | 2007 | 9621 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 9094 | 0.030 |
Why?
|
| Methylation | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Rats | 3 | 2002 | 23847 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2022 | 42684 | 0.030 |
Why?
|
| Parkinson Disease | 2 | 2020 | 2896 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1997 | 962 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 1539 | 0.030 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 169 | 0.030 |
Why?
|
| Putamen | 1 | 2015 | 293 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2000 | 1143 | 0.030 |
Why?
|
| Algorithms | 3 | 2024 | 14199 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2015 | 392 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2022 | 6346 | 0.030 |
Why?
|
| Serotonin | 1 | 1997 | 1045 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 683 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 24330 | 0.030 |
Why?
|
| Curriculum | 1 | 2006 | 3782 | 0.030 |
Why?
|
| Models, Biological | 1 | 2008 | 9499 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2862 | 0.020 |
Why?
|
| Reward | 1 | 2019 | 985 | 0.020 |
Why?
|
| Infant | 2 | 2024 | 36541 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1073 | 0.020 |
Why?
|
| Caffeine | 1 | 2016 | 703 | 0.020 |
Why?
|
| Carbon Cycle | 1 | 2011 | 16 | 0.020 |
Why?
|
| Atrophy | 1 | 2016 | 1647 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1643 | 0.020 |
Why?
|
| Skull | 1 | 2015 | 830 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2006 | 4859 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 708 | 0.020 |
Why?
|
| Parents | 1 | 2024 | 3597 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2382 | 0.020 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 600 | 0.020 |
Why?
|
| United States | 2 | 2008 | 73180 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2017 | 2202 | 0.020 |
Why?
|
| Prevalence | 1 | 2005 | 15875 | 0.020 |
Why?
|
| Hospitalization | 1 | 2008 | 10845 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2884 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1515 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7453 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2016 | 3446 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 20244 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18454 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 10778 | 0.020 |
Why?
|
| Alcoholism | 1 | 2016 | 1981 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2000 | 12809 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2014 | 1510 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11684 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2747 | 0.010 |
Why?
|
| Pandemics | 1 | 2024 | 8745 | 0.010 |
Why?
|
| Leptin | 1 | 2012 | 1597 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3613 | 0.010 |
Why?
|
| Reading | 1 | 2007 | 543 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2008 | 1256 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2009 | 2003 | 0.010 |
Why?
|
| Outpatients | 1 | 2011 | 1604 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 752 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2008 | 2269 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12093 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5801 | 0.010 |
Why?
|
| Memory | 1 | 2009 | 2210 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 508 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9528 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13677 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2014 | 6318 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8742 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7885 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2002 | 2695 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8758 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 13054 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9384 | 0.010 |
Why?
|